European Pharma Innovation May Be Outpacing U.S., Health Affairs Article Concludes
This article was originally published in The Pink Sheet Daily
Executive Summary
New Jersey professor analyzes proportion of R&D spending and proportion of NCEs in U.S., European nations and Japan, calling into question earlier Grabowski/Wang study reporting the U.S. had pulled ahead.